CClinicalTrials.gg
Status unknownNCT03827512APP-Wave-PADUpdated Jul 18, 2019

Arterial Doppler Waveforms Analysis in PAD

An observational study in French Vascular Physicians, sponsored by Rennes University Hospital. Status unknown at 1 site in France. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-07-18.

Sponsored by Rennes University Hospital · Observational

The sponsor has not verified this record recently (last verified Jul 2019), so the status shown — last known as Enrolling by invitation — may be out of date.
Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
1,000
Ages
18 Years and older
Sex
All
01

Study summary

The main objective is to evaluate the differences of terminology used when describing arterial doppler waveforms.

To assess the impact of an educational process

Read the detailed description

Peripheral artery disease (PAD) is a common pathology that affects more than 200 million people worldwide. The prevalence of this pathology is estimated in France at 11% in patients over 40 years old. The Doppler arterial waveforms analysis is an important element to assess the hemodynamic state of a patient and contributes to the diagnosis of the pathology. A number of classifications have been proposed but their use varies from one university to another. We hypothesize that there is a great heterogeneity in the description of the arterial Doppler flow analysis. In addition, a new classification (Saint-Bonnet) has recently been proposed and we will evaluate the effect of the use of this one. The main objective is to evaluate the differences of terminology used when describing arterial Doppler waveforms.

The secondary objectives are: to understand the variations observed and expected (initial, continuous training, place of exercise ...) and to study the effect of a new classification on the heterogeneity of responses.

02

Conditions studied

  • French Vascular Physicians

Keywords

  • Vascular physicians
  • Peripheral artery disease
  • classification
  • doppler waveforms
  • Saint-Bonnet
03

In context

Lead sponsor

Rennes University Hospital is the lead sponsor of 440 studies on the registry; 51 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Vascular physicians enrolled in the mailing list of French society of vascular medicine

Inclusion criteria

  • Vascular physicians enrolled in the mailing list of French society of vascular medicine

Exclusion criteria

Exclusion Criteria:

  • No exclusion criteria
05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
1,000 participants (estimated)
Patient registry
No

Interventions

  • OtherDoppler arterial waveforms analysis

    terminology used when describing arterial Doppler waveforms

06

What researchers measure

Primary outcomes

  1. Differences of terminology

    Number of different terminologies used by the vascular physicians to describe the arterial flows

    Time frame: through study completion, an average of 1 year

Secondary outcomes

  1. Effect of a new classification on the heterogeneity of terminology used

    Comparison of the number of terminology used without classification and the number of terminology used with a classification (Saint-Bonnet)

    Time frame: through study completion, an average of 1 year

  2. Variations of description of the arterial Doppler waveforms

    Significant difference in terms of heterogeneity by region or place of formation

    Time frame: through study completion, an average of 1 year

07

Study locations

1 site
  • Centre Hospitalier Universitaire de Rennes
    Rennes, 35033, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03827512
Lead sponsor
Rennes University Hospital
Collaborators
French Society of Vascular Medicine
Responsible party
Sponsor
First posted
Feb 1, 2019
Start date
Dec 1, 2018
Primary completion
Dec 31, 2022 (estimated)
Completion
Dec 31, 2022 (estimated)
Last update
Jul 18, 2019

Study contacts

Guillaume MAHE, MD PHD
principal investigator · Rennes University Hospital

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion